The public health and humanitarian implications and the newly identified nature of Corona virus have created an urgent need for both diagnostics and for therapeutics. To respond to this a call for proposals will be launched by the Innovative Medicines Initiative (IMI) in early March 2020.
Proposals submitted under this topic are expected to advance the knowledge specifically on COVID-19 and more widely on the coronavirus family with the aim of contributing to an efficient patient management and/or public health preparedness and response to current and future outbreaks of coronavirus infection. Therapeutics (excluding vaccines) and diagnostics are a particular focus of this call.
Further information can be found at: https://www.imi.europa.eu/apply-funding/future-topics
IMI will hold a webinar on IMI2 - Call 21 on Wednesday 4 March at 14:30. For details and to register, visit the webinar page at: https://www.imi.europa.eu/news-events/events/imi2-call-21-covid-19-webinar
For support to build consortia and proposals for this opportunity contact the Enterprise Europe Network team at RTC North on 01925 607 040 or via email firstname.lastname@example.org